Anixa Biosciences Stock (NASDAQ: ANIX) stock price, news, charts, stock research, profile.
Open | $3.09 |
Close | $2.89 |
Volume / Avg. | 1.47M / 87.91K |
Day Range | 2.78 - 3.13 |
52 Wk Range | 2.15 - 5.13 |
Market Cap | $92.53M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 56 |
Short Interest | 2.81% |
Days to Cover | 8.83 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Anixa Biosciences (NASDAQ:ANIX) through any online brokerage.
Other companies in Anixa Biosciences’s space includes: CytomX Therapeutics (NASDAQ:CTMX), Cellectar Biosciences (NASDAQ:CLRB), T2 Biosystems (NASDAQ:TTOO), Armata Pharmaceuticals (AMEX:ARMP) and Vistagen Therapeutics (NASDAQ:VTGN).
There is no analysis for Anixa Biosciences.
Anixa Biosciences has a consensus price target of $8.00.
The stock price for Anixa Biosciences (NASDAQ: ANIX) is $2.8909 last updated July 23, 2024 at 7:23 PM EDT.
There are no upcoming dividends for Anixa Biosciences.
Anixa Biosciences’s Q3 earnings are confirmed for Wednesday, September 4, 2024.
There is no upcoming split for Anixa Biosciences.
Anixa Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.